News | News By Subject | News by Disease News By Date | Search News

Cystic fibrosis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Your Analyst-Vetted Guide to the Five Blockbuster Drugs the FDA May Approve This Summer     5/26/2015
Vertex (VRTX) Soars After Hours as FDA Panel Backs Cystic Fibrosis Drug Orkambi     5/15/2015
Investors Hold Their Breath as Vertex (VRTX) Defends Newly Branded Cystic Fibrosis Treatment to the FDA     5/12/2015
Heart-Stopping Morning Leads to Vertex (VRTX) Rise As FDA News Sees Positives     5/11/2015
Tiny Corbus Looks to Give Vertex (VRTX) Some Competition With Experimental Cystic Fibrosis Drug     5/6/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD)     4/27/2015
Here's Why Investors are Already Anticipating Vertex (VRTX) Trial Data Coming This Month     3/17/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Vertex Pharmaceuticals (MA) (VRTX) Surges As FDA Advisory Panel Approves Kalydeco's Label Expansion     10/22/2014
InterMune, Inc. (ITMN) Goes Up On The Block; GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (France) (SAN.PA) Line Up     8/18/2014
Vertex Pharmaceuticals (MA) (VRTX) Grabs EU Recommendation For KALYDECO™ (Ivacaftor) In Eight Non-G551D Gating Mutations     6/27/2014
Vertex Pharmaceuticals (MA) (VRTX) Rockets As Cystic Fibrosis Combo Succeeds In Two Late Stage Trials     6/25/2014
Vertex Pharmaceuticals (MA) (VRTX) Trial Suggests Kalydeco May Work In More Cystic Fibrosis Patients     6/5/2014

News from Around the Web
Why Investors Shouldn't Freak Out Over Vertex (VRTX)'s Latest Trial Results     3/24/2015
Garlic Could Help Cure Lung Infection, University of Edinburgh Study     2/25/2015
University of Pittsburgh-Led Study Suggests Cystic Fibrosis Is Two Diseases, One Doesn’t Affect Lungs     7/23/2014
Cystic Fibrosis And Diabetes Link Explained, Lund University Study     6/3/2014
New Drug Target Found for Cystic Fibrosis Lung Disease, BC Children's Hospital Study     11/8/2012
Sea Sponge Chemical Fixes Cystic Fibrosis Defect, McGill University Study     10/29/2012
Differences Seen in Lung Microbes of Cystic Fibrosis Patients, Stanford University Study     10/1/2012
Big Advance Against Cystic Fibrosis: Stem Cell Researchers Create Lung Surface Tissue in a Dish, Massachusetts General Hospital Study     4/6/2012
Student, 16, Invents New Drug Cocktail to Fight Cystic Fibrosis, Wins Canadian Biotech Challenge, National Research Council of Canada laboratories Reveals     5/12/2011
Cystic Fibrosis Patients May Benefit From Combination Therapy Which Provides Hope For Cure Of Dangerous Infections, McMaster University Study     4/25/2011
New Cystic Fibrosis Drug Improves Lung Function, University of Colorado Study     12/22/2010
Novel Drug Aids CF Kids' Lungs, University of Colorado Study     12/20/2010
Drug Corrects CF Genetic Defect, University of Colorado Reveals     11/18/2010
TOBI Reduces Mortality in Patients with Cystic Fibrosis, Pa Lung Infection, Children's Hospital Boston Study     10/22/2010
One Step Closer to a Drug Treatment for Cystic Fibrosis, University of Missouri Professor Says     10/12/2010

Press Releases
Parion Sciences Announces Initiation Of Phase 2 Clinical Study Of P-1037 For The Treatment Of Cystic Fibrosis     5/6/2015
Advanced Inhalation Therapies Granted European Orphan Drug Designation For Nitric Oxide For The Treatment Of Cystic Fibrosis     5/1/2015
Cystic Fibrosis Foundation Therapeutics, Inc. Announces $14 Million Research Expansion With Genzyme (GENZ)     4/16/2015
DiscoveryBioMed Is Developing A Novel “Dual Action” Small Molecule Monotherapy For All Cystic Fibrosis (CF) Patients     4/14/2015
Vertex (VRTX) Announces Data From 12-Week Phase 2 Safety Study Of VX-661 In Combination With Ivacaftor In People With Cystic Fibrosis Who Have Two Copies Of The F508del Mutation     3/23/2015
Anthera, Inc. Announces $3 Million Research Award From Cystic Fibrosis Foundation Therapeutics, Inc. For Development Of Sollpura - A Novel Enzyme Therapy     3/20/2015
Scioderm Initiates Phase 3 Registration Trial Of Zorblisatm (SD-101), A Novel Topical Therapy For Patients With Epidermolysis Bullosa     3/19/2015
Savara's AeroVanc Meets Primary Endpoint Of MRSA Reduction In Phase 2 Trial In People With Cystic Fibrosis     2/23/2015
Tiny Startup Spyryx Looks to One-Up Vertex Pharmaceuticals (MA) (VRTX) With One-Size-Fits-All Cystic Fibrosis Therapy     2/13/2015
Advanced Inhalation Therapies Receives Orphan Drug Designation Of Its Proprietary High Dose Formulation Of Nitric Oxide For Adjunctive Treatment Of Cystic Fibrosis     2/9/2015
Celtaxsys, Inc. Lead Candidate Granted Orphan Designation In Cystic Fibrosis By FDA     2/3/2015
Vertex Pharmaceuticals Incorporated (VRTX) Outlines 2015 Business Priorities To Support The Development, Approval And Launch Of New Medicines For The Treatment Of People With Cystic Fibrosis     1/12/2015
Cystic Fibrosis Foundation Therapeutics, Inc. Announces $15 Million Research Collaboration With Shire For Development Of Novel CF Treatment     12/10/2014
FDA Grants QIDP Designation To Bayer AG (BAYZF)'s Amikacin Inhale And Ciprofloxacin Dry Powder For Inhalation     11/24/2014
Cystic Fibrosis Foundation Royalty Sale Will Be Transformational For People With CF     11/19/2014